Stage III Non-Small Cell Lung Cancer AJCC v7 Terminated Phase 1 Trials for Trametinib (DB08911)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01912625Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment